Abstract
The administration of epinephrine in oil, 1 mg free base/kg/day for 7 days to adult male dogs, resulted in significant increases in plasma and liver cholesterol concentrations. The in vitro incorporation of C14 from pyruvate-3-C14 into cholesterol, total lipid and CO2 and from mevalonate-2-C14 into cholesterol and CO2 by liver slices from epinephrine-treated dogs was not different from the metabolism of these substrates by liver slices from control dogs. Liver slices from dogs fed cholesterol for 9 to 11 days showed significant decreases in the incorporation of C14 from pyruvate-3-C14 into cholesterol. Significant increases in plasma cholesterol concentrations were observed in cholesterol-fed dogs treated with epinephrine in oil, but C14 incorporation from pyruvate-3-C14 into cholesterol was almost completely inhibited in liver slices from these dogs. Decreases in C14 incorporation from pyruvate-3-C14 into cholesterol were demonstrated in liver slices taken from cholesterol-fed dogs treated with epinephrine for 2 days. Increased plasma cholesterol concentrations in epinephrinetreated dogs, therefore, did not result from increased hepatic cholesterol synthesis. Epinephrine-induced hypercholesterolemia probably resulted from an influx of extrahepatic sterol into the liver plasma cholesterol pool.
Footnotes
- Accepted August 5, 1965.
- The Williams & Wilkins Comapny
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|